Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 927 Neoplasms 612 Breast Neoplasms 611 Colorectal Neoplasms 458 Neoplasm Metastasis 398 Ovarian Neoplasms 333 Prostatic Neoplasms 316 Melanoma 316 Lung Neoplasms 294 Multiple Myeloma 293 Recurrence 281 Squamous Cell Carcinoma of Head and Neck 248 Stomach Neoplasms 232 Pancreatic Neoplasms 231 Leukemia, Myeloid, Acute 224 Triple Negative Breast Neoplasms 193 Endometrial Neoplasms 190 Carcinoma, Renal Cell 183 Lymphoma, Non-Hodgkin 178 Carcinoma, Hepatocellular 178 Small Cell Lung Carcinoma 166 Leukemia, Lymphocytic, Chronic, B-Cell 158 Advanced Solid Tumors 158 Lymphoma, Follicular 150 Lymphoma, Large B-Cell, Diffuse 141 Urinary Bladder Neoplasms 140 Lymphoma 138 Advanced Solid Tumor 137 Uterine Cervical Neoplasms 136 Head and Neck Neoplasms 134

Interventions

trifluridine tipiracil drug combination 1 reolysin 1 atezolizumab 1 Gemcitabine 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Anal Cancer Metastatic × 1 year × Clear all

NCT07280377 2026-05-19

GOBLET

Oncolytics Biotech

Phase 1/2 Active not recruiting

Gastrointestinal

Anal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡